Standard of Care FAQ
IPA has compiled questions from pharmacy professionals regarding the updated Iowa Pharmacy Practice Act and standard of care regulatory framework. IPA has answered these questions with input from staff, members and national pharmacy experts.
Please submit your questions to IPA@iarx.org.
The following responses are not intended to be legal advice.
Q1: What is HF 555 and how is it referenced now that it is in effect?
HF 555 is legislation signed into law making comprehensive changes to the regulatory framework for the practice of pharmacy in Iowa, effective July 1, 2024. HF 555 is referred to as the Iowa Pharmacy Practice Act or Iowa Code 155A (IC 155A).
Q2: How does the Iowa Pharmacy Practice Act relate to the Iowa Board of Pharmacy (BOP) rules?
The Iowa Pharmacy Practice Act authorizes the practice of pharmacy (Iowa Code 155A) and directs the BOP to create rules (Iowa Administrative Code 481 IAC – Chapters 550-557) to implement the legislation. The rules provide more specific details of the requirements or limitations within the practice of pharmacy.
Q3: What changes to the Iowa Pharmacy Practice Act went into effect July 1, 2024?
The updated Iowa Pharmacy Practice Act brings pharmacy into alignment with other health professions using a standard of care regulatory framework. It emphasizes professional judgment and competency-based practice while maintaining core safety and ethical standards.
Pharmacists and technicians are expected to operate within the bounds of their education, training, experience, and the overall standard of care, rather than adhering to a prescriptive list of allowed or prohibited tasks. This shift allows for greater adaptability in pharmacy practice while ensuring patient safety.
The standard of care framework in the Iowa Pharmacy Practice Act emphasizes that licensees should provide a level of care that a reasonably competent and skilled health professional, with a similar background in a similar setting, would provide under similar circumstances. The standard of care benchmark guides pharmacists through these questions:
- Is the act expressly prohibited in statute or rules?
- Is the act consistent with their education, training, and experience?
- Is the act within the accepted standard of care that would be provided in a similar setting by a reasonable and prudent licensee or registrant with similar education, training, and experience?
Additional new language from HF 555 includes: therapeutic substitution, definition of practitioner, tele-pharmacy mileage restrictions, and an overall reduction in bright line language.
- Therapeutic Substitution: per the updated Iowa Pharmacy Practice Act, unless ‘dispense as written’ is noted, pharmacists can exercise professional judgment in providing therapeutic substitutions when equivalent therapeutic effect is expected, adhering to appropriate standards of care.
- The definition of ‘therapeutic substitution’ in Iowa Code 155A.3 includes "biological product" as an alternative drug or device that may be substituted.
- This process is further defined in Iowa Administrative Code 481—552.12(4) and involves:
- Patient consultation
- Clinical assessment
- Patient consent
- Documentation of consent, original medication, patient complaint, medication adjustment, rationale, follow up plan, and any additional information required by institutional policy.
- Notify the prescriber within three business days after dispensing for non-institutionalized patients or per facility policy for institutionalized patients.
- Practitioner Definition: Iowa HF 555 added “pharmacist” to the definition of “Practitioner” found in Section 155A.3, which includes prescriptive authority.
- Section 155A.8 states that pharmacists may dispense, administer, monitor, and issue prescription drugs, biological products, and medication orders commensurate with their training and education in accordance with the appropriate standard of care.
- Tele-pharmacy: Previously, Iowa Code limited where a tele-pharmacy could be in the state of Iowa, requiring a new tele-pharmacy be located at least 10 miles away from the nearest community pharmacy. In passing HF 555, this mileage requirement was removed.
Q4: How did HF 555 change the "bright line" language in previous legislation and rules, and what aspects of regulation will remain bright line?
HF 555 significantly reduced "bright-line" language, moving toward a more flexible standard of care approach.
Bright-line language provides objective legal standards that aim to:
- Make legal decisions more predictable
- Apply laws consistently and objectively
- Reduce the need for interpretation through clearly defined requirements
Examples include speed limits, voting age, and tax brackets.
While bright-line rules offer clarity and consistency, a standard of care framework allows more timely adaptation to scientific and technological advancements.
HF 555 removed:
- Specific task lists for pharmacy technicians
- Rigid guidelines for task delegation
- Detailed restrictions on pharmacist duties
Remaining bright-line requirements include:
- Prohibition on clinical decision-making by pharmacy technicians
- Statewide protocols that may be followed instead of developing pharmacy-specific policies for immunizations, Group A streptococcal pharyngitis, influenza, nicotine replacement therapy, and opioid antagonists
The approach of HF 555 emphasizes professional judgment and competency-based practice while maintaining core safety and ethical standards. Pharmacists and technicians are expected to operate within the bounds of their training and the overall standard of care, rather than adhering to a prescriptive list of allowed or prohibited tasks. This shift allows for greater adaptability in pharmacy practice while ensuring patient safety remains paramount.
Q5: Is there anything that pharmacies can STOP doing in the updated Iowa Pharmacy Practice Act?
While Iowa HF 555 did not explicitly list procedures that pharmacies can stop doing, it did remove certain restrictions and administrative burdens:
- Reduced paperwork: Pharmacies may be able to discontinue some administrative procedures related to documenting specific tasks that were previously tightly regulated.
- Fewer regulatory updates: Pharmacies will still need to update their internal policies and procedures when there is a change in pharmacy technology or practice.
- Removal of PIC application process: Pharmacies only need to report PIC changes to the Board of Pharmacy.
- Cessation of seeking specific permissions: Pharmacies and pharmacists may be able to stop the practice of seeking explicit permission from legislators or regulators for each new service or technology they want to implement, if it falls within the standard of care and the pharmacist’s education, training and experience.
- Discontinuation of rigid technician task delegation: Pharmacies can stop rigid task delegation and instead use professional judgment to assign technicians non-clinical duties based on individual competence under the standard of care in accordance with their individual education, training, and experience.
Q6: What is the difference between scope of practice and clinical ability?
- Scope of practice: What you may legally do under regulation.
- Clinical ability: What you can do based on your education, training, and skills.
- Scope of practice applies to the profession as a whole, while clinical ability varies from one individual to another.
Q7: How do pharmacists and technicians best prepare to practice under a standard of care regulatory model?
Pharmacists and technicians should ask themselves three guiding questions to practice under a standard of care regulatory framework as they prepare to update roles and responsibilities:
- Is the practice expressly prohibited by statute or rules?
- Is the practice consistent with your education, training, and experience?
- Is the practice consistent with what would be provided in a similar setting by a reasonable and prudent pharmacist with similar education, training, and experience?
Organizations should also review and update:
- Policies
- Standard operating procedures
- Job descriptions
- Training programs
- Quality assurance programs
- Continuous quality improvement plans
Q8: Does HF 555 require payment for pharmacist services?
No, HF 555 does not require or prohibit payment for pharmacist services. IPA continues to advocate for payers to provide payment for pharmacist services. Additionally, Iowa Medicaid recognizes pharmacists as providers and has approved a list of payable codes for payment for pharmacy services.
Q9: What changes relate to collaborative practice / collaborative drug therapy management agreements?
The previous bright-line guidance on CPAs has been updated. Pharmacists are not required to practice with a CPA if their professional activities fall under the standard of care but may enter into a CPA if applicable to the practice or organization as referenced in 481 IAC 552.27.
Q10: Do existing CPAs need to be updated pursuant to the new practice act or BOP rules?
No, nothing needs to change for existing CPAs. Under the updated Pharmacy Practice Act, there is greater flexibility to update and add new CPAs pursuant to patient care needs, pharmacist training, and collaborative care opportunities.
Q11: Are pharmacy technicians regulated under the standard of care framework?
Yes. Pharmacy technicians are regulated under the standard of care regulatory framework.
Q12: What changes directly impact pharmacy technicians?
Pharmacy technician functions remain limited to non-clinical tasks as clinical decision making remains the responsibility of licensed pharmacists. Other considerations include:
- Removal of Bright-Line Language: The new legislation removes much of the previous "bright-line" language that explicitly detailed what technicians could or could not do.
- Emphasis on Pharmacist Professional Judgment: The removal of specific technician task lists places greater emphasis on the pharmacist's professional judgment in delegating non-clinical tasks to technicians. Pharmacists must assess a technician's competence and determine task delegation based on the standard of care including the education, training, and experience of the technician rather than through a predefined list.
- Expanded Role Opportunity: The standard of care potentially opens the door for technicians to take on expanded roles, provided they are working within the scope of their education, training, experience, and under appropriate supervision.
Q13: Does the Pharmacist in Charge (PIC) role remain?
Q14: What happens if a compliance officer disagrees with an activity we do, even if a group of reasonably competent pharmacists agree?
The Board of Pharmacy will develop a formal review process pursuant to complaints or citations that may likely include subject matter experts to help inform any final decisions ultimately made by the Board of Pharmacy. They will use resources from experts in the field, standards across the country and standards in the state of Iowa to determine if the activity in question was appropriate.
Q15: Are there any changes to pharmacist criminal history checks?
Yes, the Board of Pharmacy may now request criminal history data for any applicant for an initial or renewal license or registration, as well as for licensees or registrants being monitored because of a board order or agreement resolving an administrative disciplinary action.

.jpg)